DZ2912A1 - Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé. - Google Patents

Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.

Info

Publication number
DZ2912A1
DZ2912A1 DZ990212A DZ990212A DZ2912A1 DZ 2912 A1 DZ2912 A1 DZ 2912A1 DZ 990212 A DZ990212 A DZ 990212A DZ 990212 A DZ990212 A DZ 990212A DZ 2912 A1 DZ2912 A1 DZ 2912A1
Authority
DZ
Algeria
Prior art keywords
düpyrimidine
pyrazolo
intermediates
ones
preparation
Prior art date
Application number
DZ990212A
Other languages
English (en)
French (fr)
Inventor
Research Development Co Pfizer
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2912(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of DZ2912A1 publication Critical patent/DZ2912A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ990212A 1998-10-12 1999-10-11 Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé. DZ2912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
DZ2912A1 true DZ2912A1 (fr) 2004-03-01

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990212A DZ2912A1 (fr) 1998-10-12 1999-10-11 Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.

Country Status (49)

Country Link
US (3) US6207829B1 (xx)
EP (1) EP0994115B1 (xx)
JP (1) JP3721021B2 (xx)
KR (1) KR100380954B1 (xx)
CN (2) CN1473831A (xx)
AP (1) AP1233A (xx)
AR (1) AR019244A1 (xx)
AT (1) ATE290003T1 (xx)
AU (1) AU756463B2 (xx)
BG (1) BG63205B1 (xx)
BR (1) BR9905092A (xx)
CA (1) CA2285733C (xx)
CO (1) CO5150214A1 (xx)
CR (1) CR6118A (xx)
CU (1) CU22928A3 (xx)
CZ (1) CZ296816B6 (xx)
DE (1) DE69923906T2 (xx)
DK (1) DK0994115T3 (xx)
DZ (1) DZ2912A1 (xx)
EA (1) EA003774B1 (xx)
EE (1) EE04192B1 (xx)
EG (1) EG22630A (xx)
ES (1) ES2237049T3 (xx)
GB (1) GB9822238D0 (xx)
GE (1) GEP20022700B (xx)
GT (1) GT199900172A (xx)
HK (1) HK1027559A1 (xx)
HR (1) HRP990318B1 (xx)
HU (1) HU226162B1 (xx)
ID (1) ID23351A (xx)
IL (11) IL152924A (xx)
IS (1) IS1951B (xx)
MA (1) MA25007A1 (xx)
MY (1) MY124620A (xx)
NO (1) NO313700B1 (xx)
OA (1) OA11165A (xx)
PE (1) PE20001086A1 (xx)
PL (1) PL198150B1 (xx)
PT (1) PT994115E (xx)
RS (1) RS49762B (xx)
SG (1) SG118060A1 (xx)
SI (1) SI0994115T1 (xx)
SK (1) SK285215B6 (xx)
TN (1) TNSN99189A1 (xx)
TR (1) TR199902541A2 (xx)
TW (1) TW589314B (xx)
UA (1) UA66787C2 (xx)
UY (1) UY25750A1 (xx)
ZA (1) ZA996412B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078760A1 (fr) * 1999-06-21 2000-12-28 The Biochemical Pharmaceutical Factory Of Zhuhai Sez Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
ES2223863T3 (es) * 2000-06-22 2005-03-01 Pfizer Inc. Procedimiento para la preparacion de pirazolopirimidinonas.
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
US7335680B2 (en) 2001-12-20 2008-02-26 Laboratoires Serono Sa Pyrrolidine derivatives as prostaglandin modulators
JP4361800B2 (ja) * 2001-12-21 2009-11-11 サイトキネティックス， インコーポレイテッド 心不全を処置するための組成物および方法
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) * 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
KR100390612B1 (ko) * 1997-04-25 2003-07-07 화이자 인코포레이티드 타입 5 시클릭 구아노신 3',5'-모노포스페이트포스포디에스테라제를 억제하는 성기능 장애 치료용피라졸로피리미디논 제조용 중간체의 제조 방법

Also Published As

Publication number Publication date
IL132273A0 (en) 2001-03-19
HUP9903469A3 (en) 2000-10-30
ATE290003T1 (de) 2005-03-15
CA2285733A1 (en) 2000-04-12
KR20000028987A (ko) 2000-05-25
GB9822238D0 (en) 1998-12-09
US20030069422A1 (en) 2003-04-10
CZ353299A3 (cs) 2000-05-17
SI0994115T1 (xx) 2005-08-31
SK138599A3 (en) 2000-05-16
IL152928A (en) 2007-07-04
HRP990318A2 (en) 2000-06-30
SK285215B6 (sk) 2006-09-07
BG63205B1 (bg) 2001-06-29
AU5358199A (en) 2000-04-13
IL152927A0 (en) 2003-06-24
CU22928A3 (es) 2004-02-20
IL152926A0 (en) 2003-06-24
HU9903469D0 (en) 1999-12-28
US20010009962A1 (en) 2001-07-26
CA2285733C (en) 2004-08-24
CR6118A (es) 2005-09-16
EG22630A (en) 2003-05-31
EE9900507A (et) 2000-06-15
PL198150B1 (pl) 2008-05-30
US6207829B1 (en) 2001-03-27
PE20001086A1 (es) 2000-10-18
IL132273A (en) 2004-06-20
HRP990318B1 (en) 2004-06-30
GEP20022700B (en) 2002-05-27
TR199902541A2 (xx) 2000-07-21
ID23351A (id) 2000-04-13
YU48999A (sh) 2002-06-19
CO5150214A1 (es) 2002-04-29
DE69923906T2 (de) 2006-04-06
CN1207295C (zh) 2005-06-22
EP0994115A3 (en) 2000-05-24
AR019244A1 (es) 2001-12-26
JP3721021B2 (ja) 2005-11-30
NO994943D0 (no) 1999-10-11
EE04192B1 (et) 2003-12-15
MA25007A1 (fr) 2000-07-01
ZA996412B (en) 2001-04-11
CN1255497A (zh) 2000-06-07
AU756463B2 (en) 2003-01-16
IS5209A (is) 2000-04-13
TNSN99189A1 (fr) 2005-11-10
IL152927A (en) 2004-06-01
DK0994115T3 (da) 2005-06-20
UY25750A1 (es) 2001-08-27
EP0994115A2 (en) 2000-04-19
BG103794A (en) 2000-09-29
EA199900822A3 (ru) 2000-08-28
TW589314B (en) 2004-06-01
IL152923A (en) 2004-02-08
IL152928A0 (en) 2003-06-24
MY124620A (en) 2006-06-30
NO994943L (no) 2000-04-13
EA003774B1 (ru) 2003-08-28
PL335959A1 (en) 2000-04-25
AP1233A (en) 2003-12-18
AP9901672A0 (en) 1999-12-31
NO313700B1 (no) 2002-11-18
IS1951B (is) 2004-10-13
GT199900172A (es) 2001-03-28
CZ296816B6 (cs) 2006-06-14
IL152924A (en) 2004-02-19
ES2237049T3 (es) 2005-07-16
EP0994115B1 (en) 2005-03-02
UA66787C2 (en) 2004-06-15
HUP9903469A2 (hu) 2000-08-28
CN1473831A (zh) 2004-02-11
IL152923A0 (en) 2003-06-24
KR100380954B1 (ko) 2003-04-21
EA199900822A2 (ru) 2000-04-24
HK1027559A1 (en) 2001-01-19
JP2000119273A (ja) 2000-04-25
SG118060A1 (en) 2006-01-27
OA11165A (en) 2003-04-22
BR9905092A (pt) 2000-08-08
HU226162B1 (en) 2008-05-28
RS49762B (sr) 2008-04-04
IL152924A0 (en) 2003-06-24
IL152926A (en) 2004-02-19
PT994115E (pt) 2005-06-30
DE69923906D1 (de) 2005-04-07

Similar Documents

Publication Publication Date Title
DZ2247A1 (fr) Procédé pour la préparation du sildénafil.
DZ2912A1 (fr) Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
MA23143A1 (fr) Procede pour la preparation de compositions vaccinantes .
FR2749778B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
FR2764211B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
DZ1946A1 (fr) Procédé pour la préparation de supports.
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
DZ2637A1 (fr) Procédé de production de thiazolidinediones substituées.
DZ2607A1 (fr) Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
DZ3096A1 (fr) Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
ZA993902B (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds.
DZ2746A1 (fr) Nouveau procédé de préparation de la fexofénadine.
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
ZA982255B (en) Process for the preparation of arylmalonates.
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
MA24464A1 (fr) Procede de preparation de composes nouveaux .
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
DK0729959T3 (da) Fremgangsmåde til fremstilling af loracarbefmonohydrat
FR2719580B1 (fr) Procédé de préparation d'octadiénols.